当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析

瑞普生物

(300119)

  

流通市值:57.29亿  总市值:79.80亿
流通股本:3.34亿   总股本:4.65亿

瑞普生物(300119)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.17亿元,每股收益0.24元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益527164.93万元,未分配利润215967.52万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产780232.50万元,负债253067.57万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入826,126,074.243,398,458,452.832,544,325,031.331,707,587,656.8
营业总成本704,661,498.033,020,087,411.562,202,944,319.051,464,234,653.83
其他经营收益
营业利润128,605,155.19479,584,919.95442,271,734.21312,125,190.45
利润总额128,463,443.95470,690,631.32440,509,317.26311,509,253.46
净利润117,408,841.8434,469,249.03390,791,557.17272,063,586.89
每股收益
其他综合收益-45,528.73--
综合收益总额117,408,841.8434,514,777.76390,791,557.17272,063,586.89
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,535,224,928.893,374,603,369.093,612,103,316.773,701,102,337.82
非流动资产:
非流动资产合计4,267,100,088.624,281,306,339.534,078,784,932.184,253,878,532.19
资产总计7,802,325,017.517,655,909,708.627,690,888,248.957,954,980,870.01
流动负债:
流动负债合计1,958,380,391.591,889,607,060.91,732,829,381.221,999,138,395.07
非流动负债:
非流动负债合计572,295,322.64581,679,198.83808,016,106.08864,968,236.98
负债合计2,530,675,714.232,471,286,259.732,540,845,487.32,864,106,632.05
所有者权益(或股东权益):
归属于母公司股东权益合计4,810,861,219.674,703,083,000.414,673,159,600.714,561,894,007.01
股东权益合计5,271,649,303.285,184,623,448.895,150,042,761.655,090,874,237.96
负债和股东权益合计7,802,325,017.517,655,909,708.627,690,888,248.957,954,980,870.01
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计761,602,097.673,503,825,792.523,018,090,6081,935,001,493.84
经营活动现金流出小计750,252,571.143,206,292,174.122,812,210,302.781,799,627,801.88
经营活动产生的现金流量净额11,349,526.53297,533,618.4205,880,305.22135,373,691.96
投资活动产生的现金流量:
投资活动现金流入小计488,420,119.412,915,162,422.532,254,967,689.981,076,066,931.54
投资活动现金流出小计641,646,806.272,812,937,992.052,194,680,681.971,074,938,614.84
投资活动产生的现金流量净额-153,226,686.86102,224,430.4860,287,008.011,128,316.7
筹资活动产生的现金流量:
筹资活动现金流入小计175,498,061.651,194,901,963.01889,326,044.79774,941,779.39
筹资活动现金流出小计116,425,634.461,445,368,104.291,145,081,425.34854,950,006.69
筹资活动产生的现金流量净额59,072,427.19-250,466,141.28-255,755,380.55-80,008,227.3
汇率变动对现金及现金等价物的影响-517,499.31-1,817.85196,030.85172,814.38
现金及现金等价物净增加额-83,322,232.45149,290,089.7510,607,963.5356,666,595.74
期末现金及现金等价物余额542,193,720.84625,515,953.29486,833,827.07532,892,459.28
补充资料:
现金及现金等价物的净增加额-149,290,089.75-56,666,595.74
最新报告期:2026-05-02
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
天风证券吴立,陈潇,陈炼1.081.401.622026-05-02
国泰海通林逸丹,王艳君0.921.171.432026-05-01
华创证券陈鹏0.911.251.602026-04-30
中金公司王思洋,龙友琪0.891.00--2026-04-29
中金公司王思洋,龙友琪0.891.00--2026-04-09
TOP↑